Adage Capital Management, L.P. 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 09:03 am Sale | 2025-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 2,432,000 4.500% | -2,157,000 (-47.00%) | Filing |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 4,589,000 8.500% | 1,589,000 (+52.97%) | Filing |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 3,000,000 5.560% | 3,000,000 (New Position) | Filing |